Sionna Therapeutics, Inc.（SION）内部人交易：高管与董事近期交易
过去 18 个月，共有 17 位内部人为 Sionna Therapeutics, Inc.（SION）报告了 439 笔 Form 4 交易（最近一笔 2026-09-21）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-21 | RA Capital Healthcare Fund LP | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | Kolchinsky Peter | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | Shah Rajeev M. | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | RA Capital Nexus Fund, L.P. | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | RA Capital Nexus Fund III, L.P. | 董事 | 卖出 | 3.4M | $21.6M |
| 2026-09-21 | RA Capital Healthcare Fund LP | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-21 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-21 | Kolchinsky Peter | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-21 | Shah Rajeev M. | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-21 | RA Capital Nexus Fund, L.P. | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-21 | RA Capital Nexus Fund III, L.P. | 董事 | 卖出 | 33,800 | $252,148 |
| 2026-09-18 | Cloonan Michael | President & CEO | 买入 | 109,025 | $0 |
| 2026-09-18 | Ridloff Elena | CFO and CBO | 买入 | 47,269 | $0 |
| 2026-09-18 | McKee Charlotte | CMO and Head of R&D | 买入 | 50,000 | $0 |
| 2026-09-18 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | 买入 | 28,133 | $0 |
| 2026-09-18 | Cloonan Michael | President & CEO | 买入 | 109,025 | $0 |
| 2026-09-18 | Ridloff Elena | CFO and CBO | 买入 | 47,268 | $0 |
| 2026-09-18 | McKee Charlotte | CMO and Head of R&D | 买入 | 50,000 | $0 |
| 2026-09-18 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | 买入 | 28,132 | $0 |
| 2026-07-09 | ORBIMED ADVISORS LLC | 董事 | 卖出 | 85,918 | $3.9M |
| 2026-07-09 | Thompson Peter A. | 董事 | 卖出 | 85,918 | $3.9M |
| 2026-07-09 | OrbiMed Capital GP VIII LLC | 董事 | 卖出 | 85,918 | $3.9M |
| 2026-07-07 | Fitzpatrick Jennifer | Chief Legal Officer | 买入 | 10,250 | $62,628 |
| 2026-07-07 | Fitzpatrick Jennifer | Chief Legal Officer | 卖出 | 10,250 | $446,862 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21